You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GS-6624

Showing 1 - 25 of 271
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in United States (Simtuzumab, Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Scottsdale, Arizona
  • +6 more
Jun 17, 2020

Liver Fibrosis, Hepatitis C, HIV Trial run by the (Simtuzumab)

Completed
Has Results
  • Liver Fibrosis
  • +3 more
  • Simtuzumab
  • Bethesda, Maryland
    NIH Department of Laboratory Medicine
Oct 22, 2019

Primary Sclerosing Cholangitis (PSC) Trial in Worldwide (Simtuzumab, Placebo)

Completed
Has Results
  • Primary Sclerosing Cholangitis (PSC)
  • Simtuzumab
  • Placebo
  • Phoenix, Arizona
  • +74 more
Oct 3, 2019

Liver Fibrosis Due to NASH Trial in Worldwide (Placebo, SIM)

Terminated
Has Results
  • Liver Fibrosis Due to NASH
  • Placebo
  • SIM
  • Phoenix, Arizona
  • +58 more
Mar 1, 2019

Non-Alcoholic Steatohepatitis (NASH) Trial in Canada, United States (SEL, SIM)

Completed
Has Results
  • Non-Alcoholic Steatohepatitis (NASH)
  • Palo Alto, California
  • +27 more
May 31, 2019

Liver Fibrosis Due to NASH Trial in Worldwide (Placebo, SIM)

Terminated
Has Results
  • Liver Fibrosis Due to NASH
  • Placebo
  • SIM
  • Phoenix, Arizona
  • +67 more
Mar 1, 2019

Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • (no location specified)
Sep 4, 2023

Alcohol Consumption Trial in Palo Alto (Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS))

Enrolling by invitation
  • Alcohol Consumption
  • Control
  • +2 more
  • Palo Alto, California
    Stanford University
May 8, 2023

Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)

Not yet recruiting
  • Chronic Hepatitis B
  • GS-2829
  • +3 more
  • (no location specified)
Mar 14, 2023

Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))

Not yet recruiting
  • Genetic Predisposition
  • Next-Generation Sequencing (NGS)
  • Tübingen, Germany
    University Hospital Tübingen
Sep 22, 2023

Gastroschisis Trial in Houston (fetoscopy)

Recruiting
  • Gastroschisis
  • fetoscopy
  • Houston, Texas
    Texas Children's Hospital
Jan 20, 2023

HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

Not yet recruiting
  • HIV Infections
  • Teropavimab
  • +4 more
  • (no location specified)
Feb 6, 2023

Solid Tumors Trial (GS-9911, Zimberelimab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Oct 9, 2023

Solid Tumor Trial (GS-4528, Zimberelimab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Apr 21, 2023

STEMI - ST Elevation Myocardial Infarction Trial

Not yet recruiting
  • STEMI - ST Elevation Myocardial Infarction
    • (no location specified)
    Dec 24, 2022

    HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

    Active, not recruiting
    • HIV-1 Infection
    • Oral Lenacapavir
    • +3 more
    • Los Angeles, California
    • +22 more
    Nov 4, 2022

    COVID-19 Trial (GS-5245, GS-5245 Placebo)

    Not yet recruiting
    • COVID-19
    • (no location specified)
    Feb 3, 2023

    COVID-19 Trial in Canada, Poland, Romania (GS-5245, GS-5245 Placebo)

    Recruiting
    • COVID-19
    • Hamilton, Canada
    • +8 more
    Jan 24, 2023

    HIV-1-infection Trial in United States (GS-5894, B/F/TAF, Standard of Care)

    Recruiting
    • HIV-1-infection
    • Los Angeles, California
    • +15 more
    Jan 13, 2023

    Stroke Trial in Venice (real tACS, sham tACS)

    Recruiting
    • Stroke
    • real tACS
    • sham tACS
    • Venice, Italy
      IRCCS San Camillo Hospital
    Apr 13, 2023

    Advanced Solid Tumors Trial in United States (GS-3583)

    Active, not recruiting
    • Advanced Solid Tumors
    • Grand Rapids, Michigan
    • +3 more
    Jul 22, 2022

    Sexual Health Trial in Taoyuan (Received the GS-SHEP)

    Completed
    • Sexual Health
    • Received the GS-SHEP
    • Taoyuan, Guishan Dist., Taiwan
      Cheng Gung Memorial Hospital
    Mar 5, 2023

    Cutaneous Lupus Erythematosus Trial in United States (GS-5718, Placebo)

    Terminated
    • Cutaneous Lupus Erythematosus
    • Beverly Hills, California
    • +4 more
    Nov 17, 2022

    Prediabetic State, Overweight Trial (Verum A, Verum B, Placebo)

    Not yet recruiting
    • Prediabetic State
    • Overweight
    • Verum A
    • +2 more
    • (no location specified)
    Jun 29, 2023

    Solid Malignancies Trial in United States (GS-9716, Docetaxel, Sacituzumab Govitecan-hziy)

    Recruiting
    • Solid Malignancies
    • Grand Rapids, Michigan
    • +4 more
    Jul 13, 2022